This is Money
UK · 19 mins ago
AstraZeneca in £20bn hit after heart disease drug hoped to be a potential blockbuster flops in trials
Astra's shares tumbled 10.5% after it said its Wainua drug - which it is developing with Ionis - failed to reduce deaths related to heart disease.
Do you trust This is Money?
Sign in to rate
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!